Atossa Genetics PE Ratio 2012-2023 | ATOS
Current and historical p/e ratio for Atossa Genetics (ATOS) from 2012 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Atossa Genetics PE ratio as of May 09, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Atossa Genetics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-09 | 1.69 | 0.00 | |
| 2023-12-31 | 0.88 | $-0.24 | 0.00 |
| 2023-09-30 | 0.74 | $-0.24 | 0.00 |
| 2023-06-30 | 1.26 | $-0.25 | 0.00 |
| 2023-03-31 | 0.72 | $-0.22 | 0.00 |
| 2022-12-31 | 0.53 | $-0.21 | 0.00 |
| 2022-09-30 | 0.83 | $-0.19 | 0.00 |
| 2022-06-30 | 1.09 | $-0.17 | 0.00 |
| 2022-03-31 | 1.25 | $-0.18 | 0.00 |
| 2021-12-31 | 1.60 | $-0.18 | 0.00 |
| 2021-09-30 | 3.26 | $-1.03 | 0.00 |
| 2021-06-30 | 6.32 | $-1.33 | 0.00 |
| 2021-03-31 | 2.11 | $-1.70 | 0.00 |
| 2020-12-31 | 0.95 | $-1.98 | 0.00 |
| 2020-09-30 | 2.42 | $-1.35 | 0.00 |
| 2020-06-30 | 3.80 | $-1.37 | 0.00 |
| 2020-03-31 | 1.33 | $-1.74 | 0.00 |
| 2019-12-31 | 1.57 | $-2.04 | 0.00 |
| 2019-09-30 | 1.96 | $-1.78 | 0.00 |
| 2019-06-30 | 2.55 | $-4.32 | 0.00 |
| 2019-03-31 | 3.52 | $-4.23 | 0.00 |
| 2018-12-31 | 1.02 | $-3.61 | 0.00 |
| 2018-06-30 | 2.20 | $-5.77 | 0.00 |
| 2018-03-31 | 5.35 | $-10.55 | 0.00 |
| 2017-12-31 | 3.16 | $-15.25 | 0.00 |
| 2017-09-30 | 6.36 | $-28.21 | 0.00 |
| 2017-06-30 | 6.00 | $-25.21 | 0.00 |
| 2017-03-31 | 9.12 | $-26.53 | 0.00 |
| 2016-12-31 | 16.92 | $-33.72 | 0.00 |
| 2016-09-30 | 25.20 | $-20.76 | 0.00 |
| 2016-06-30 | 50.40 | $-48.60 | 0.00 |
| 2016-03-31 | 61.92 | $-59.39 | 0.00 |
| 2015-12-31 | 57.60 | $-70.19 | 0.00 |
| 2015-09-30 | 138.60 | $-113.39 | 0.00 |
| 2015-06-30 | 203.40 | $-109.79 | 0.00 |
| 2015-03-31 | 324.00 | $-131.39 | 0.00 |
| 2014-12-31 | 257.40 | $-125.99 | 0.00 |
| 2014-09-30 | 243.00 | $-109.79 | 0.00 |
| 2014-06-30 | 302.40 | $-87.03 | 0.00 |
| 2014-03-31 | 304.20 | $-85.23 | 0.00 |
| 2013-12-31 | 417.60 | $-97.83 | 0.00 |
| 2018-09-30 | 1.75 | $-96.03 | 0.00 |
| 2013-09-30 | 1011.60 | $-115.19 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.212B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.605B | 26.73 |
| Intuitive Surgical (ISRG) | United States | $136.719B | 82.36 |
| Edwards Lifesciences (EW) | United States | $52.679B | 34.28 |
| DexCom (DXCM) | United States | $50.959B | 77.19 |
| IQVIA Holdings (IQV) | United States | $41.760B | 24.23 |
| IDEXX Laboratories (IDXX) | United States | $41.361B | 48.48 |
| Alcon (ALC) | Switzerland | $40.168B | 29.62 |
| STERIS (STE) | Ireland | $22.331B | 26.10 |
| Waters (WAT) | United States | $19.956B | 29.33 |
| Hologic (HOLX) | United States | $17.678B | 19.78 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.647B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.410B | 77.23 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.253B | 14.30 |
| Sysmex ADR (SSMXY) | Japan | $10.794B | 33.85 |
| Teleflex (TFX) | United States | $9.642B | 15.01 |
| Globus Medical (GMED) | United States | $8.713B | 25.54 |
| Penumbra (PEN) | United States | $8.117B | 92.25 |
| Masimo (MASI) | United States | $6.591B | 37.97 |
| Glaukos (GKOS) | United States | $5.421B | 0.00 |
| TransMedics (TMDX) | United States | $4.241B | 402.41 |
| Integer Holdings (ITGR) | United States | $3.827B | 23.12 |
| LivaNova (LIVN) | United Kingdom | $3.355B | 19.92 |
| PROCEPT BioRobotics (PRCT) | United States | $3.240B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.845B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.744B | 18.83 |
| Inari Medical (NARI) | United States | $2.470B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.449B | 20.72 |
| RxSight (RXST) | United States | $2.272B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.994B | 8.69 |
| Alphatec Holdings (ATEC) | United States | $1.586B | 0.00 |
| Veracyte (VCYT) | United States | $1.577B | 0.00 |
| Artivion (AORT) | United States | $0.977B | 93.60 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.894B | 17.38 |
| OPKO Health (OPK) | United States | $0.878B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.805B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.798B | 0.00 |
| Paragon 28 (FNA) | United States | $0.684B | 0.00 |
| SiBone (SIBN) | United States | $0.640B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.632B | 21.45 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.542B | 0.00 |
| IRadimed (IRMD) | United States | $0.541B | 30.28 |
| Pacific Biosciences Of California (PACB) | United States | $0.468B | 0.00 |
| Nevro (NVRO) | United States | $0.386B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.384B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.334B | 11.42 |
| Sight Sciences (SGHT) | United States | $0.277B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.275B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.262B | 0.00 |
| AxoGen (AXGN) | United States | $0.261B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.245B | 0.00 |
| NeuroPace (NPCE) | United States | $0.229B | 0.00 |
| Inogen (INGN) | United States | $0.205B | 0.00 |
| 908 Devices (MASS) | United States | $0.199B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.172B | 0.00 |
| Accuray (ARAY) | United States | $0.168B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.168B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.162B | 8.23 |
| CVRx (CVRX) | United States | $0.158B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.154B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.100B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Envoy Medical (COCH) | United States | $0.066B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.063B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 13.14 |
| Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.057B | 0.00 |
| InspireMD (NSPR) | Israel | $0.052B | 0.00 |
| DarioHealth (DRIO) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
| LENSAR (LNSR) | United States | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| PAVmed (PAVM) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |